Report Detail

Other Global Glycated Haemoglobin Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4601175
  • |
  • 20 July, 2024
  • |
  • Global
  • |
  • 132 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

According to our (Global Info Research) latest study, the global Glycated Haemoglobin Testing market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Growing adoption of a sedentary lifestyle and genetic manipulation causes type 1 or type 2 diseases. Globally, more than 400 million adults suffer from diabetes, out of which half of the incidences of diabetes remain undiagnosed.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Glycated Haemoglobin Testing industry chain, the market status of Hospitals (Lab Based Test, Point-of-care Test), Diagnostic Centers (Lab Based Test, Point-of-care Test), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Glycated Haemoglobin Testing.
Regionally, the report analyzes the Glycated Haemoglobin Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Glycated Haemoglobin Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Glycated Haemoglobin Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Glycated Haemoglobin Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Lab Based Test, Point-of-care Test).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Glycated Haemoglobin Testing market.
Regional Analysis: The report involves examining the Glycated Haemoglobin Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Glycated Haemoglobin Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Glycated Haemoglobin Testing:
Company Analysis: Report covers individual Glycated Haemoglobin Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Glycated Haemoglobin Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Diagnostic Centers).
Technology Analysis: Report covers specific technologies relevant to Glycated Haemoglobin Testing. It assesses the current state, advancements, and potential future developments in Glycated Haemoglobin Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Glycated Haemoglobin Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Glycated Haemoglobin Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Lab Based Test
Point-of-care Test
Market segment by Application
Hospitals
Diagnostic Centers
Academic and Research Institutes
Others
Market segment by players, this report covers
Bio-Rad Laboratories
Bayer
Arkray
Chek Diagnostics
Diazyme Laboratories
X Lite-On Technology
TaiDoc Technology
Trinity Biotech
Siemens Healthcare
Ceragem Medisys
Tosoh Bioscience
DiaSys Diagnostic Systems
Erba Mannheim
Daiichi Biotech
Human Diagnostics
EKF Diagnostics
Mindray Medical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Glycated Haemoglobin Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Glycated Haemoglobin Testing, with revenue, gross margin and global market share of Glycated Haemoglobin Testing from 2019 to 2024.
Chapter 3, the Glycated Haemoglobin Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Glycated Haemoglobin Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Glycated Haemoglobin Testing.
Chapter 13, to describe Glycated Haemoglobin Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Glycated Haemoglobin Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Glycated Haemoglobin Testing by Type
    • 1.3.1 Overview: Global Glycated Haemoglobin Testing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Glycated Haemoglobin Testing Consumption Value Market Share by Type in 2023
    • 1.3.3 Lab Based Test
    • 1.3.4 Point-of-care Test
  • 1.4 Global Glycated Haemoglobin Testing Market by Application
    • 1.4.1 Overview: Global Glycated Haemoglobin Testing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Diagnostic Centers
    • 1.4.4 Academic and Research Institutes
    • 1.4.5 Others
  • 1.5 Global Glycated Haemoglobin Testing Market Size & Forecast
  • 1.6 Global Glycated Haemoglobin Testing Market Size and Forecast by Region
    • 1.6.1 Global Glycated Haemoglobin Testing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Glycated Haemoglobin Testing Market Size by Region, (2019-2030)
    • 1.6.3 North America Glycated Haemoglobin Testing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Glycated Haemoglobin Testing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Glycated Haemoglobin Testing Market Size and Prospect (2019-2030)
    • 1.6.6 South America Glycated Haemoglobin Testing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Glycated Haemoglobin Testing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Bio-Rad Laboratories
    • 2.1.1 Bio-Rad Laboratories Details
    • 2.1.2 Bio-Rad Laboratories Major Business
    • 2.1.3 Bio-Rad Laboratories Glycated Haemoglobin Testing Product and Solutions
    • 2.1.4 Bio-Rad Laboratories Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Glycated Haemoglobin Testing Product and Solutions
    • 2.2.4 Bayer Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Bayer Recent Developments and Future Plans
  • 2.3 Arkray
    • 2.3.1 Arkray Details
    • 2.3.2 Arkray Major Business
    • 2.3.3 Arkray Glycated Haemoglobin Testing Product and Solutions
    • 2.3.4 Arkray Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Arkray Recent Developments and Future Plans
  • 2.4 Chek Diagnostics
    • 2.4.1 Chek Diagnostics Details
    • 2.4.2 Chek Diagnostics Major Business
    • 2.4.3 Chek Diagnostics Glycated Haemoglobin Testing Product and Solutions
    • 2.4.4 Chek Diagnostics Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Chek Diagnostics Recent Developments and Future Plans
  • 2.5 Diazyme Laboratories
    • 2.5.1 Diazyme Laboratories Details
    • 2.5.2 Diazyme Laboratories Major Business
    • 2.5.3 Diazyme Laboratories Glycated Haemoglobin Testing Product and Solutions
    • 2.5.4 Diazyme Laboratories Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Diazyme Laboratories Recent Developments and Future Plans
  • 2.6 X Lite-On Technology
    • 2.6.1 X Lite-On Technology Details
    • 2.6.2 X Lite-On Technology Major Business
    • 2.6.3 X Lite-On Technology Glycated Haemoglobin Testing Product and Solutions
    • 2.6.4 X Lite-On Technology Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 X Lite-On Technology Recent Developments and Future Plans
  • 2.7 TaiDoc Technology
    • 2.7.1 TaiDoc Technology Details
    • 2.7.2 TaiDoc Technology Major Business
    • 2.7.3 TaiDoc Technology Glycated Haemoglobin Testing Product and Solutions
    • 2.7.4 TaiDoc Technology Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 TaiDoc Technology Recent Developments and Future Plans
  • 2.8 Trinity Biotech
    • 2.8.1 Trinity Biotech Details
    • 2.8.2 Trinity Biotech Major Business
    • 2.8.3 Trinity Biotech Glycated Haemoglobin Testing Product and Solutions
    • 2.8.4 Trinity Biotech Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Trinity Biotech Recent Developments and Future Plans
  • 2.9 Siemens Healthcare
    • 2.9.1 Siemens Healthcare Details
    • 2.9.2 Siemens Healthcare Major Business
    • 2.9.3 Siemens Healthcare Glycated Haemoglobin Testing Product and Solutions
    • 2.9.4 Siemens Healthcare Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Siemens Healthcare Recent Developments and Future Plans
  • 2.10 Ceragem Medisys
    • 2.10.1 Ceragem Medisys Details
    • 2.10.2 Ceragem Medisys Major Business
    • 2.10.3 Ceragem Medisys Glycated Haemoglobin Testing Product and Solutions
    • 2.10.4 Ceragem Medisys Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Ceragem Medisys Recent Developments and Future Plans
  • 2.11 Tosoh Bioscience
    • 2.11.1 Tosoh Bioscience Details
    • 2.11.2 Tosoh Bioscience Major Business
    • 2.11.3 Tosoh Bioscience Glycated Haemoglobin Testing Product and Solutions
    • 2.11.4 Tosoh Bioscience Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Tosoh Bioscience Recent Developments and Future Plans
  • 2.12 DiaSys Diagnostic Systems
    • 2.12.1 DiaSys Diagnostic Systems Details
    • 2.12.2 DiaSys Diagnostic Systems Major Business
    • 2.12.3 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Product and Solutions
    • 2.12.4 DiaSys Diagnostic Systems Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 DiaSys Diagnostic Systems Recent Developments and Future Plans
  • 2.13 Erba Mannheim
    • 2.13.1 Erba Mannheim Details
    • 2.13.2 Erba Mannheim Major Business
    • 2.13.3 Erba Mannheim Glycated Haemoglobin Testing Product and Solutions
    • 2.13.4 Erba Mannheim Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Erba Mannheim Recent Developments and Future Plans
  • 2.14 Daiichi Biotech
    • 2.14.1 Daiichi Biotech Details
    • 2.14.2 Daiichi Biotech Major Business
    • 2.14.3 Daiichi Biotech Glycated Haemoglobin Testing Product and Solutions
    • 2.14.4 Daiichi Biotech Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Daiichi Biotech Recent Developments and Future Plans
  • 2.15 Human Diagnostics
    • 2.15.1 Human Diagnostics Details
    • 2.15.2 Human Diagnostics Major Business
    • 2.15.3 Human Diagnostics Glycated Haemoglobin Testing Product and Solutions
    • 2.15.4 Human Diagnostics Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Human Diagnostics Recent Developments and Future Plans
  • 2.16 EKF Diagnostics
    • 2.16.1 EKF Diagnostics Details
    • 2.16.2 EKF Diagnostics Major Business
    • 2.16.3 EKF Diagnostics Glycated Haemoglobin Testing Product and Solutions
    • 2.16.4 EKF Diagnostics Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 EKF Diagnostics Recent Developments and Future Plans
  • 2.17 Mindray Medical
    • 2.17.1 Mindray Medical Details
    • 2.17.2 Mindray Medical Major Business
    • 2.17.3 Mindray Medical Glycated Haemoglobin Testing Product and Solutions
    • 2.17.4 Mindray Medical Glycated Haemoglobin Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Mindray Medical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Glycated Haemoglobin Testing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Glycated Haemoglobin Testing by Company Revenue
    • 3.2.2 Top 3 Glycated Haemoglobin Testing Players Market Share in 2023
    • 3.2.3 Top 6 Glycated Haemoglobin Testing Players Market Share in 2023
  • 3.3 Glycated Haemoglobin Testing Market: Overall Company Footprint Analysis
    • 3.3.1 Glycated Haemoglobin Testing Market: Region Footprint
    • 3.3.2 Glycated Haemoglobin Testing Market: Company Product Type Footprint
    • 3.3.3 Glycated Haemoglobin Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Glycated Haemoglobin Testing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Glycated Haemoglobin Testing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Glycated Haemoglobin Testing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Glycated Haemoglobin Testing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Glycated Haemoglobin Testing Consumption Value by Type (2019-2030)
  • 6.2 North America Glycated Haemoglobin Testing Consumption Value by Application (2019-2030)
  • 6.3 North America Glycated Haemoglobin Testing Market Size by Country
    • 6.3.1 North America Glycated Haemoglobin Testing Consumption Value by Country (2019-2030)
    • 6.3.2 United States Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Glycated Haemoglobin Testing Consumption Value by Type (2019-2030)
  • 7.2 Europe Glycated Haemoglobin Testing Consumption Value by Application (2019-2030)
  • 7.3 Europe Glycated Haemoglobin Testing Market Size by Country
    • 7.3.1 Europe Glycated Haemoglobin Testing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 7.3.3 France Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Glycated Haemoglobin Testing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Glycated Haemoglobin Testing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Glycated Haemoglobin Testing Market Size by Region
    • 8.3.1 Asia-Pacific Glycated Haemoglobin Testing Consumption Value by Region (2019-2030)
    • 8.3.2 China Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 8.3.5 India Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Glycated Haemoglobin Testing Consumption Value by Type (2019-2030)
  • 9.2 South America Glycated Haemoglobin Testing Consumption Value by Application (2019-2030)
  • 9.3 South America Glycated Haemoglobin Testing Market Size by Country
    • 9.3.1 South America Glycated Haemoglobin Testing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Glycated Haemoglobin Testing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Glycated Haemoglobin Testing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Glycated Haemoglobin Testing Market Size by Country
    • 10.3.1 Middle East & Africa Glycated Haemoglobin Testing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Glycated Haemoglobin Testing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Glycated Haemoglobin Testing Market Drivers
  • 11.2 Glycated Haemoglobin Testing Market Restraints
  • 11.3 Glycated Haemoglobin Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Glycated Haemoglobin Testing Industry Chain
  • 12.2 Glycated Haemoglobin Testing Upstream Analysis
  • 12.3 Glycated Haemoglobin Testing Midstream Analysis
  • 12.4 Glycated Haemoglobin Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Glycated Haemoglobin Testing. Industry analysis & Market Report on Glycated Haemoglobin Testing is a syndicated market report, published as Global Glycated Haemoglobin Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Glycated Haemoglobin Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,641.32
    3,961.98
    5,282.64
    3,128.52
    4,692.78
    6,257.04
    492,802.80
    739,204.20
    985,605.60
    291,728.40
    437,592.60
    583,456.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report